Vascular Anomalies

Surgical Clinics of North America

Volumn 86, Issue 2, 2006, Pages 393-425

  Christison Lagay, Emily R ^a   Fishman, Steven J ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PICIBANIL; PREDNISOLONE; RECOMBINANT ALPHA2A INTERFERON; TRIAMCINOLONE; VINCRISTINE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ANEMIA; ARTIFICIAL EMBOLISM; CONGENITAL BLOOD VESSEL MALFORMATION; DIFFERENTIAL DIAGNOSIS; FEVER; HEART FAILURE; HEMANGIOMA; HUMAN; KASABACH MERRITT SYNDROME; LOW LEVEL LASER THERAPY; LYMPHATIC SYSTEM DISEASE; MICROANGIOPATHY; MOEBIUS SYNDROME; NEUROLOGIC DISEASE; NEUTROPENIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; REVIEW; SCLEROTHERAPY; SURGICAL TECHNIQUE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; ULCER; VASCULAR TUMOR; VEIN MALFORMATION;

BLOOD VESSELS; CARDIOVASCULAR ABNORMALITIES; CHILD; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; HUMANS; VASCULAR SURGICAL PROCEDURES;

EID: 33645862870     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2005.12.017     Document Type: Review

References (94)

1. Mulliken J.B., and Young A.E. Vascular birthmarks: hemangiomas and malformations (1988), WB Saunders, Philadelphia
2. Virchow R. Angioma in die krankhaften geschwu{combining double acute accent}lste (1863), Hirshwald, Berlin p. 306-425
3. Vikkula M., et al. Molecular basis of vascular anomalies. Trends Cardiovasc Med 8 7 (1998) 281-292
4. Holmdahl K. Cutaneous hemangiomas in premature and mature infants. Acta Paediatr Scand 44 (1955) 370-379
5. Amir J., Metzker A., Krikler R., et al. Strawberry hemangioma in preterm infants. Pediatr Dermatol 3 (1986) 331-332
6. Marchuk D.A. Pathogenesis of hemangioma. J Clin Invest 107 6 (2001) 665-666
7. Boye E., Yu Y., Paranya G., et al. Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest 107 6 (2001) 745-752
8. Cheung D.S., Warmen M.L., and Mulliken J.B. Hemangioma in twins. Ann Plast Surg 38 (1997) 269-274
9. Mulliken J.B., and Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 69 (1982) 412-420
10. Boon L.M., Enjolras O., and Mulliken J.B. Congenital hemangioma: evidence of accelerated involution. J Pediatr 128 (1996) 329-335
11. Finn M.C., Glowacki J., and Mulliken J.B. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg 18 (1983) 894-900
12. Razon M.J., Kraling B.M., Mulliken J.B., et al. Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation 5 2-3 (1998) 188-195
13. Bowers R.E., Graham E.A., and Tomlinson K.M. The natural history of the strawberry birthmark. Arch Dermatol 82 (1960) 667-680
14. Dadras S.S., North P.E., et al. Infantile hemangiomas are arrested in an early developmental vascular differentiation state. Mod Pathol 17 (2004) 1068-1079
15. Bree A.F., Siegfried E., et al. Infantile hemangiomas: speculation on placental trophoblastic origin. Arch Dermatol 137 5 (2001) 573-577
16. North P.E., Waner M., Miterzaki A., et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 137 5 (2001) 559-570
17. Leon-Villapalos J., Wolfe K., and Kangesu L. GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations. Br J Plast Surg 58 3 (2005) 348-352
18. Huang S.A., et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 343 3 (2000) 185-189
19. Barnes CM, Huang S, Kaipainen A, et al. Evidence by molecular profiling for a placental origin of infantile hemangioma. PNAS, in press.
20. Tille J.C., and Pepper M.S. Hereditary vascular anomalies: new insights into their pathogenesis. Arterioscler Thromb Vasc Biol 24 (2004) 1578-1590
21. Chang J., Most D., Bresnick S., et al. Proliferative hemangiomas: analysis of cytokine gene expression and angiogenesis. Plast Reconstr Surg 103 (1999) 1-10
22. Takahashi K., Mulliken J.B., et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 93 (1994) 2357-2364
23. Pasqual-Castroviejo I., Viano J., Moreno F., et al. Hemangiomas of the head, neck and chest with associated vascular brain anomalies: a complex neurocutaneous syndrome. AJNR Am J Neuroradiol 17 (1996) 461-471
24. Burrows P.E., Robertson R.L., Mulliken J.B., et al. Cerebral vasculopathy and neurologic sequelae in infants with cervicofacial hemangioma: report of eight patients. Radiology 207 (1998) 601-607
25. Frieden I.J., Reese V., and Cohen D. PHACE syndrome: the association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarcation of the aorta and cardiac defects and eye abnormalities. Arch Dermatol 132 (1996) 307-311
26. Goldberg N.S., Hebert A.A., and Esterly N.B. Sacral hemangiomas and multiple congenital abnormalities. Arch Dermatol 122 (1986) 684-687
27. Albright A.L., Gartner J.C., and Wiener E.S. Lumbar cutaneous hemangiomas as indicators of tethered spinal cords. Pediatrics 83 (1989) 977-980
28. Kasabach H.H., and Merritt K.K. Capillary hemangioma with extensive purpura: report of a case. Am J Dis Child 59 (1940) 1063-1070
29. Lyons L.L., North P.E., Mac-Moune L.F., et al. Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol 28 5 (2004) 559-568
30. Enjolras O., Wassef M., Mazoyer E., et al. Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas. J Pediatr 130 (1997) 631-640
31. Sarkar M., Mulliken J.B., Kozakewich H.P., et al. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg 100 (1997) 1377-1386
32. Jones E.W., and Orkin M. Tufted angioma (angioblastoma): a benign progressive angioma, not to be confused with Kaposi's sarcoma or low grade angiosarcoma. J Am Acad Dermatol 20 (1989) 214-225
33. Martinez-Perez D., Fine N.A., Boon L.M., et al. Not all hemangiomas look like strawberries: uncommon presentations of the most common tumor of infancy. Pediatr Dermatol 12 (1995) 1-6
34. Patrice S.J., Wiss K., and Mulliken J.B. Pyogenic granuloma (lobular capillary hemangioma): a clinicopathologic of 178 cases. Pediatr Dermatol 8 (1991) 267-276
35. Chung K.C., Weiss S.W., and Kuzon Jr. W.M. Multifocal congenital hemangiopericytomas associated with Kasabach-Merritt syndrome. Br J Plast Surg 48 (1995) 240-242
36. Boon L.M., Fishman S.J., Lund D.P., et al. Congenital fibrosarcoma masquerading as congenital hemangioma: report of two cases. J Pediatr Surg 30 (1995) 1378-1381
37. Margileth A.M., and Museles M. Cutaneous hemangiomas in children: diagnosis and conservative management. JAMA 194 (1965) 523-526
38. Morelli J.G., Tan O.T., Yohn J.J., et al. Treatment of ulcerated hemangiomas in infancy. Arch Pediatr Adolesc Med 148 (1994) 1104-1105
39. Enjolras O., and Gelbert F. Superficial hemangiomas: associations and management. Pediatr Dermatol 14 (1997) 174-179
40. Orlow S.J., Isakoff M.S., and Blei F. Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a "beard" distribution. J Pediatr 131 (1997) 643-646
41. Enjolras O., Riche M.C., Merland J.J., et al. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 85 (1990) 491-498
42. White C.W., Wolf S.J., Korones D.N., et al. Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a. J Pediatr 118 (1991) 59-66
43. Ezekowitz R.A.B., Mulliken J.B., and Folkman J. Interferon alpha-2a therapy for life-threatening hemangiomas of infancy and childhood. N Engl J Med 326 (1992) 1456-1463
44. Grienwald J.H., Burke D.K., Bonthius D.J., et al. An update on the treatment of hemangiomas in children with interferon alpha-2a. Arch Otolaryngol Head Neck Surg 125 (1999) 21-27
45. Barlow C.F., Preibe C.J., Mulliken J.B., et al. Spastic diplegia as a complication of interferon alpha-2a treatment of hemangiomas of infancy. J Pediatr 132 3 Pt 1 (1998) 527-530
46. Perez J., Pardo J., and Gomez C. Vincristine: an effective treatment of corticoid-resistant life-threatening infantile hemangiomas. Acta Oncol 41 2 (2002) 197-199
47. Haisley-Royster C., Enjolras O., Frieden I.J., et al. Kasabach-Merritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol 24 6 (2002) 459-462
48. Sie K.C., McGill T., and Healy G.B. Subglottic hemangioma: ten years' experience with carbon dioxide laser. Ann Otol Rhinol Laryngol 103 (1994) 167-172
49. Ramsauer M., and D'Amore P.A. Getting Tie(2)d up in angiogenesis. J Clin Invest 110 (2002) 1615-1617
50. Rodriguez-Niedenfuhr M., Papoutsi M., Christ B., et al. Prox1 is a marker of ectodermal placodes, endodermal compartments, lymphatic endothelium and lymphangioblasts. Anat Embryol (Berl) 204 (2001) 399-406
51. Oliver G. Lymphatic vasculature development. Nat Rev Immunol 4 (2004) 35-45
52. Bellomo D., Headrick J.P., Silins G.U., et al. Mice lacking the vascular endothelial growth factor-B gene (VEGF-b) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ Res 86 (2000) E29-E36
53. Jussila L., and Alitalo K. Vascular growth factors and lymphangiogenesis. Physiol Rev 82 (2002) 673-700
54. Dumont D.J., Jussila L., Taipale J., et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor 3. Science 282 (1998) 946-949
55. Sato R.N., Tozawa Y., Deutsch U., et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376 (1995) 70-74
56. Puri M.C., Rossant J., Alitalo K., et al. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J 14 (1995) 5884-5891
57. Suri C., Jones P.F., Patan S., et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87 (1996) 1171-1180
58. Maisonpierre P.C., Suri C., Jones P.F., et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277 (1997) 55-60
59. Dickson M.C., Martin J.S., Cousins F.M., et al. Defective haematopoiesis and vasculogenesis in transforming growth factor-β 1 knock out mice. Development 121 (1995) 1845-1854
60. Shawber C.J., and Kitajewski J. Notch function in the vasculature: insights from zebrafish, mouse and man. Bioessays 26 (2004) 225-234
61. Soldi R., Mitola S., et al. Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 18 (1999) 882-892
62. Smoller B.R., and Rosen S. Port-wine stains: a disease of altered neural modulation of blood vessels?. Arch Dermatol 122 (1986) 177-179
63. Breugem C.C., Alders M., Salieb-Beugelaar G.B., et al. A locus for hereditary capillary malformations mapped on chromosome 5q. Hum Genet 110 (2002) 343-347
64. Eerola I., Boon L.M., Mulliken J.B., et al. Capillary malformation-arteriovenous malformation: a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 73 (2003) 1240-1249
65. Tan O.T., Sherwood K., and Gilchrest B.A. Treatment of children with port wine stains using the flashlamp pumped tunable dye laser. N Engl J Med 320 (1989) 416-421
66. van der Horst C.M., Koster P.H., deBorgie C.A., et al. Effect of the timing of treatment of port-wine stains with the flash lamp pulsed dye laser. N Engl J Med 338 (1998) 1028-1033
67. McAllister K.A., Grogg K.M., Johnson D.W., et al. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type I. Nat Genet 8 (1994) 345-351
68. Johnson D.W., Berg J.N., et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13 (1996) 189-195
69. Johnson D.W., Berg J.N., Baldwin M.A., et al. A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. Hum Mol Genet 12 (2003) 473-482
70. Lee J.H., and Paull T.T. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science 308 5721 (2005) 551-554
71. Puig S., Casati B., Staudenherz A., et al. Vascular low-flow malformations in children: current concepts for classification, diagnosis and therapy. Eur J Radiol 53 (2005) 35-45
72. Fishman S.J., Burrows P.E., Upton J., et al. Life-threatening anomalies of the thoracic duct: anatomic delineation dictates management. J Pediatr Surg 36 8 (2001) 1269-1272
73. Padwa B.L., Hayward P.G., Ferraro N.F., et al. Cervicofacial lymphatic malformation, clinical course, surgical intervention, and pathogenesis of skeletal hypertrophy. Plast Reconstr Surg 95 (1995) 951-960
74. Gorham L.W., and Stout A.P. Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone): its relations to hemangiomatosis. J Bone Joint Surg Am 37 (1955) 986-1004
75. Karkkainen M.J., Ferrell R.E., Lawrence E.C., et al. Missense mutations interfere with VEGFR-3 signaling in primary lymphoedema. Nat Genet 25 (2000) 153-159
76. Irrthum A., Karkkainen M.J., Devriendt K., et al. Congenital hereditary lymphedema caused by a mutations that inactivates VEGFR3. Am J Hum Genet 67 (2000) 295-301
77. Fang J., Dagenais S.L., Erickson R.P., et al. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet 67 (2000) 1382-1388
78. Ogita S., Tsuto T., Nakamura K., et al. OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg 29 (1994) 784-785
79. Algahtani A., Nguyen L.T., Flageole H., et al. 25 years' experience with lymphangiomas in children. J Pediatr Surg 34 (1999) 1164-1168
80. Brouillard P., Boon L.M., Mulliken J.B., et al. Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ("glomangiomas"). Am J Hum Genet 70 (2002) 866-874
81. Boon L.M., Mulliken J.B., Vikkula M., et al. Assignment of a locus for dominantly inherited venous malformations to chromosome 9. Hum Mol Genet 3 (1994) 1583-1587
82. Vikkula M., Boon L.M., Carraway K.L., et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87 (1996) 1181-1190
83. Laberge-le C.S., Jung H.H., Houtteville J.P., et al. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet 23 (1999) 189-193
84. Zhang J., Clatterbuck R.E., Rigamonti D., et al. Interaction between krit1 and icap1α infers perturbation of integrin β1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum Mol Genet 10 (2001) 2953-2960
85. Oranje A.P. Blue rubber bleb nevus syndrome. Pediatr Dermatol 3 (1986) 304-310
86. Fishman S.J., Burrows P.E., Leichtner A.M., et al. Gastrointestinal manifestations of vascular anomalies in childhood. J Pediatr Surg 33 (1998) 1163-1167
87. Smithers C.J., Vogel A.M., Kozakewich H.P., et al. An injectable tissue-engineered embolus prevents luminal recanalization after vascular sclerotherapy. J Pediatr Surg 40 (2005) 920-925
88. Fishman S.J., Smithers C.J., Folkman J., et al. Blue rubber bleb nevus syndrome: surgical eradication of gastrointestinal bleeding. Ann Surg 241 3 (2005) 523-528
89. Fishman S.J., Shamberger R.C., Fox V.L., et al. Endorectal pull-through abates gastrointestinal hemorrhage for colorectal venous malformations. J Pediatr Surg 35 (2000) 982-984
90. Kohout M.P., Hansen M., Pribaz J.J., et al. Arteriovenous malformations of the head and neck: natural history and management. Plast Reconstr Surg 102 (1998) 643-654
91. Gloviczki P., Stanson A.W., Stickler G.B., et al. Klippel-Trenaunay syndrome: the risks and benefits of vascular interventions. Surgery 110 (1991) 469-479
92. Baskerville P.A., Akroyd J.S., Thomas M.L., et al. The Klippel-Trenaunay syndrome: clinical, radiological, and hemodynamic features and management. Br J Surg 82 (1985) 757-761
93. Yanez S., Val-Bernal J.F., Mira C., et al. Spindle cell hemangioendotheliomas associated with multiple skeletal enchondromas: a variant of Maffucci's syndrome. Gen Diagn Pathol 143 (1998) 331-335
94. Sun T.-C., Swee R.G., Shives T.C., et al. Chondrosarcoma in Maffucci's syndrome. J Bone Joint Surg Am 67 (1985) 1214-1219